| AS703026 |
1236699-92-5 |
AS703026 is a novel, selective, orally bioavailable mitogen-activated protein kinase (MEK) 1/2 inhibitor, in human multiple myeloma (MM).... |
| AS703026 |
1236699-92-5 |
AS703026 is a novel, selective, orally bioavailable mitogen-activated protein kinase (MEK) 1/2 inhibitor, in human multiple myeloma (MM).... |
| AS703026 |
1236699-92-5 |
AS703026 is a novel, selective, orally bioavailable mitogen-activated protein kinase (MEK) 1/2 inhibitor, in human multiple myeloma (MM).... |
| AS703026 |
1236699-92-5 |
AS703026 is a novel, selective, orally bioavailable mitogen-activated protein kinase (MEK) 1/2 inhibitor, in human multiple myeloma (MM).... |
| AZD6244 |
606143-52-6 |
AZD6244 is a potent, selective, and ATP-uncompetitive inhibitor of MEK1/2 kinases.... |
| AZD6244 |
606143-52-6 |
AZD6244 is a potent, selective, and ATP-uncompetitive inhibitor of MEK1/2 kinases.... |
| AZD6244 |
606143-52-6 |
AZD6244 is a potent, selective, and ATP-uncompetitive inhibitor of MEK1/2 kinases.... |
| AZD6244 |
606143-52-6 |
AZD6244 is a potent, selective, and ATP-uncompetitive inhibitor of MEK1/2 kinases.... |
| BIX 02188 |
1094614-84-2 |
BIX02188 is a selective and potent MEK5 inhibitor.... |
| BIX 02188 |
1094614-84-2 |
BIX02188 is a selective and potent MEK5 inhibitor.... |
| BIX 02188 |
1094614-84-2 |
BIX02188 is a selective and potent MEK5 inhibitor.... |
| BIX 02188 |
1094614-84-2 |
BIX02188 is a selective and potent MEK5 inhibitor.... |
| BIX 02189 |
1094614-85-3 |
BIX02189 is a selective and potent MEK5 inhibitor.... |
| BIX 02189 |
1094614-85-3 |
BIX02189 is a selective and potent MEK5 inhibitor.... |
| BIX 02189 |
1094614-85-3 |
BIX02189 is a selective and potent MEK5 inhibitor.... |
| BIX 02189 |
1094614-85-3 |
BIX02189 is a selective and potent MEK5 inhibitor.... |
| CCT239065 |
1163719-51-4 |
CCT239065 is a BRAFV600E inhibitor.... |
| CEP-32496 |
1188910-76-0 |
CEP-32496 is a potent BRAF inhibitor.... |
| CEP-32496 |
1188910-76-0 |
CEP-32496 is a potent BRAF inhibitor.... |
| CEP-32496 |
1188910-76-0 |
CEP-32496 is a potent BRAF inhibitor.... |
| CI-1040 |
212631-79-3 |
CI-1040 is a small-molecule with highly selective adenosine triphosphate (ATP) non-competitive inhibition activity against MEK1/2.... |
| CI-1040 |
212631-79-3 |
CI-1040 is a small-molecule with highly selective adenosine triphosphate (ATP) non-competitive inhibition activity against MEK1/2.... |
| CI-1040 |
212631-79-3 |
CI-1040 is a small-molecule with highly selective adenosine triphosphate (ATP) non-competitive inhibition activity against MEK1/2.... |
| CI-1040 |
212631-79-3 |
CI-1040 is a small-molecule with highly selective adenosine triphosphate (ATP) non-competitive inhibition activity against MEK1/2.... |
| CI-1040 |
212631-79-3 |
CI-1040 is a small-molecule with highly selective adenosine triphosphate (ATP) non-competitive inhibition activity against MEK1/2.... |
| CPI-613 |
95809-78-2 |
CPI-613 is a non-redox active lipoate derivative that selectively inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase.... |
| CPI-613 |
95809-78-2 |
CPI-613 is a non-redox active lipoate derivative that selectively inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase.... |
| CPI-613 |
95809-78-2 |
CPI-613 is a non-redox active lipoate derivative that selectively inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase.... |
| CPI-613 |
95809-78-2 |
CPI-613 is a non-redox active lipoate derivative that selectively inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase.... |
| Dabrafenib |
1195765-45-7 |
.... |
| Dabrafenib Mesylate |
1195768-06-9 |
Dabrafenib mesylate is a mutant-BRAF kinase inhibitor.... |
| Dabrafenib Mesylate |
1195768-06-9 |
Dabrafenib mesylate is a mutant-BRAF kinase inhibitor.... |
| Dabrafenib Mesylate |
1195768-06-9 |
Dabrafenib mesylate is a mutant-BRAF kinase inhibitor.... |
| Dabrafenib Mesylate |
1195768-06-9 |
Dabrafenib mesylate is a mutant-BRAF kinase inhibitor.... |
| GDC-0879 |
905281-76-7 |
GDC-0879 is a highly selective and orally bioavailable RAF small-molecule inhibitor.... |
| GSK1120212 |
871700-17-3 |
GSK1120212 is a selective and highly potent MEK1 and MEK2 inhibitor with IC50 values of 1.8 and 0.92 nM, respectively.... |
| GSK1120212 |
871700-17-3 |
GSK1120212 is a selective and highly potent MEK1 and MEK2 inhibitor with IC50 values of 1.8 and 0.92 nM, respectively.... |
| GSK1120212 |
871700-17-3 |
GSK1120212 is a selective and highly potent MEK1 and MEK2 inhibitor with IC50 values of 1.8 and 0.92 nM, respectively.... |
| JNK-IN-8 |
1410880-22-6 |
.... |
| LY2228820 |
862507-23-1 |
LY2228820 is a novel p38 mitogen-activated protein kinase (p38MAPK) inhibitor.... |
| Nilotinib |
641571-10-0 |
Nilotinib inhibits the kinases BCR-ABL, KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11 and ZAK.... |
| Nilotinib |
641571-10-0 |
Nilotinib inhibits the kinases BCR-ABL, KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11 and ZAK.... |
| Nilotinib |
641571-10-0 |
Nilotinib inhibits the kinases BCR-ABL, KIT, LCK, EPHA3, EPHA8, DDR1, DDR2, PDGFRB, MAPK11 and ZAK.... |
| PD0325901 |
391210-10-9 |
PD0325901 is selective and non ATP-competitive mitogenic extracellular kinase 1/2 (MEK1/2) inhibitor with an IC50 of 0.33 nM.... |
| PD0325901 |
391210-10-9 |
PD0325901 is selective and non ATP-competitive mitogenic extracellular kinase 1/2 (MEK1/2) inhibitor with an IC50 of 0.33 nM.... |
| PD0325901 |
391210-10-9 |
PD0325901 is selective and non ATP-competitive mitogenic extracellular kinase 1/2 (MEK1/2) inhibitor with an IC50 of 0.33 nM.... |
| PD0325901 |
391210-10-9 |
PD0325901 is selective and non ATP-competitive mitogenic extracellular kinase 1/2 (MEK1/2) inhibitor with an IC50 of 0.33 nM.... |
| PD318088 |
391210-00-7 |
PD318088 is a non-ATP competitive MEK inhibitor.... |
| PD98059 |
167869-21-8 |
PD98059 is a specific inhibitor of mitogen-activated protein kinase kinase (MEK).... |
| PD98059 |
167869-21-8 |
PD98059 is a specific inhibitor of mitogen-activated protein kinase kinase (MEK).... |
| PD98059 |
167869-21-8 |
PD98059 is a specific inhibitor of mitogen-activated protein kinase kinase (MEK).... |
| Pelitinib |
257933-82-7 |
.... |
| Pelitinib |
257933-82-7 |
.... |
| Pelitinib |
257933-82-7 |
.... |
| |
|
|
| PH-797804 |
586379-66-0 |
PH-797804 is an inhibitor of the α isoform of human p38 mitogen-active protein kinase (MAPK).... |
| PLX-4032 |
918504-65-1 |
PLX-4032 is a potent small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma.... |
| PLX-4032 |
918504-65-1 |
PLX-4032 is a potent small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma.... |
| PLX-4032 |
918504-65-1 |
PLX-4032 is a potent small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma.... |
| PLX4720 |
918505-84-7 |
PLX4720 inhibits B-RafV600E with an IC50 of 13 nM, defines a class of kinase inhibitor with marked selectivity in both biochemical and cellular assays.... |
| PLX4720 |
918505-84-7 |
PLX4720 inhibits B-RafV600E with an IC50 of 13 nM, defines a class of kinase inhibitor with marked selectivity in both biochemical and cellular assays.... |
| PLX4720 |
918505-84-7 |
PLX4720 inhibits B-RafV600E with an IC50 of 13 nM, defines a class of kinase inhibitor with marked selectivity in both biochemical and cellular assays.... |
| R406(Free base） |
841290-80-0 |
.... |
| RAF265 |
927880-90-8 |
RAF265 is a selective and potent inhibitor of RAF and VEGFR2.... |
| RAF265 |
927880-90-8 |
RAF265 is a selective and potent inhibitor of RAF and VEGFR2.... |
| SB 202190 |
152121-30-7 |
SB202190 is an effective and selective inhibitor of p38 with an IC50 of 30 nM.... |
| SB 202190 |
152121-30-7 |
SB202190 is an effective and selective inhibitor of p38 with an IC50 of 30 nM.... |
| SB 203580 |
152121-47-6 |
SB203580 is a selective cytokine suppressive binding protein/p38 kinase (p38 MAPK) inhibitor.... |
| SB 203580 |
152121-47-6 |
SB203580 is a selective cytokine suppressive binding protein/p38 kinase (p38 MAPK) inhibitor.... |
| SB 203580 |
152121-47-6 |
SB203580 is a selective cytokine suppressive binding protein/p38 kinase (p38 MAPK) inhibitor.... |
| SB 203580 |
152121-47-6 |
SB203580 is a selective cytokine suppressive binding protein/p38 kinase (p38 MAPK) inhibitor.... |
| Skepinone-L |
1221485-83-1 |
.... |
| Skepinone-L |
1221485-83-1 |
.... |
| Sorafenib |
284461-73-0 |
Sorafenib is a small molecular inhibitor of several tyrosine protein kinases including VEGFR (vascular endothelial growth factor receptors) and PDGFR (platelet-derived growth factor receptors) and Raf kinases.... |
| Sorafenib |
284461-73-0 |
Sorafenib is a small molecular inhibitor of several tyrosine protein kinases including VEGFR (vascular endothelial growth factor receptors) and PDGFR (platelet-derived growth factor receptors) and Raf kinases.... |
| Sorafenib |
284461-73-0 |
Sorafenib is a small molecular inhibitor of several tyrosine protein kinases including VEGFR (vascular endothelial growth factor receptors) and PDGFR (platelet-derived growth factor receptors) and Raf kinases.... |
| Sorafenib |
284461-73-0 |
Sorafenib is a small molecular inhibitor of several tyrosine protein kinases including VEGFR (vascular endothelial growth factor receptors) and PDGFR (platelet-derived growth factor receptors) and Raf kinases.... |
| Sorafenib tosylate |
475207-59-1 |
.... |
| Sorafenib tosylate |
475207-59-1 |
.... |
| Sorafenib tosylate |
475207-59-1 |
.... |
| Sorafenib tosylate |
475207-59-1 |
.... |
| SP600125 |
129-56-6 |
SP600125 is a selective inhibitor of Jun N-terminal kinase (JNK).... |
| SP600125 |
129-56-6 |
SP600125 is a selective inhibitor of Jun N-terminal kinase (JNK).... |
| SP600125 |
129-56-6 |
SP600125 is a selective inhibitor of Jun N-terminal kinase (JNK).... |
| TAK-632 |
1228591-30-7 |
TAK-632 is a potent pan-RAF inhibitor.... |
| TAK-733 |
1035555-63-5 |
TAK-733 is a potent and selective MEK inhibitor.... |
| TAK-733 |
1035555-63-5 |
TAK-733 is a potent and selective MEK inhibitor.... |
| TAK-733 |
1035555-63-5 |
TAK-733 is a potent and selective MEK inhibitor.... |
| TAK-733 |
1035555-63-5 |
TAK-733 is a potent and selective MEK inhibitor.... |
| TAK715 |
303162-79-0 |
.... |
| TAK715 |
303162-79-0 |
.... |
| U0126 |
109511-58-2 |
U0126 is a highly selective inhibitor of both MEK1 and MEK2 which are human extracellular signal-regulated kinase activator kinases.... |
| U0126 |
109511-58-2 |
U0126 is a highly selective inhibitor of both MEK1 and MEK2 which are human extracellular signal-regulated kinase activator kinases.... |
| U0126 |
109511-58-2 |
U0126 is a highly selective inhibitor of both MEK1 and MEK2 which are human extracellular signal-regulated kinase activator kinases.... |
| U0126 |
109511-58-2 |
U0126 is a highly selective inhibitor of both MEK1 and MEK2 which are human extracellular signal-regulated kinase activator kinases.... |
| Vx-702 |
745833-23-2 |
VX-702 is a highly selective novel p38 MAPK inhibitor.... |
| Vx-702 |
745833-23-2 |
VX-702 is a highly selective novel p38 MAPK inhibitor.... |
| Vx-702 |
745833-23-2 |
VX-702 is a highly selective novel p38 MAPK inhibitor.... |
| Vx-702 |
745833-23-2 |
VX-702 is a highly selective novel p38 MAPK inhibitor.... |
| XMD 8-92 |
1234480-50-2 |
.... |
| ZM 336372 |
208260-29-1 |
.... |
点击图片查看原图
